Financial Network Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Financial Network Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.2K	Hold	66	–	–	0.04%	306
2026 Q1	$51K	Buy	66 +34	+106%	+$26K	0.05%	276
2025 Q4	$24.7K	Buy	32 +3	+10%	+$2.04K	0.03%	364
2025 Q3	$16.3K	Buy	29 +11	+61%	+$6.22K	0.02%	395
2025 Q2	$9.45K	Buy	18 +6	+50%	+$3.35K	0.01%	444
2025 Q1	$7.61K	Buy	12 +4	+50%	+$2.75K	0.01%	450
2024 Q4	$5.7K	Sell	8 -5	-38%	-$4.2K	0.01%	347
2024 Q3	$13.7K	Buy	13 +4	+44%	+$4.45K	0.01%	410
2024 Q2	$9.46K	Buy	+9	New	+$8.72K	0.01%	496

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Financial Network Wealth Advisors's REGN Position: Q2 2026 in Review

Financial Network Wealth Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 66 shares worth $41.2K. The position accounts for 0.04% of the portfolio, ranked #306.

Financial Network Wealth Advisors first reported a position in REGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $51K in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Financial Network Wealth Advisors held 66 shares of Regeneron Pharmaceuticals worth $41.2K as of Q2 2026.
Financial Network Wealth Advisors left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.04% of Financial Network Wealth Advisors's portfolio in Q2 2026, its #306 holding.
Financial Network Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Financial Network Wealth Advisors's Regeneron Pharmaceuticals position peaked at $51K in Q1 2026.
1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.